Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching

JACC: Cardiovascular Imaging

Volumn 5, Issue 10, 2012, Pages 1014-1021

  Iqbal, Fahad M ^a   Hage, Fadi G ^b,c   Ahmed, Ali ^b,c   Dean, Phillip J ^d   Raslan, Saleem ^b   Heo, Jaekyeong ^b   Iskandrian, Ami E ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

myocardial perfusion imaging; prognosis; regadenoson; single photon emission computed tomography; stress testing; vasodilator

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; LOOP DIURETIC AGENT; METFORMIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON; SPIRONOLACTONE; SULFONYLUREA;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; AGED; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PURINES; PYRAZOLES; REFERENCE VALUES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 84867382259     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.04.009     Document Type: Article

References (34)

1. S.M. Navare, J.F. Mather, L.J. Shaw, M.S. Fowler, G.V. Heller Comparison of risk stratification with pharmacological and exercise stress myocardial perfusion imaging: a meta-analysis J Nucl Cardiol 11 2004 551 561
2. K.A. Brown Prognostic value of myocardial perfusion imaging: state of the art and new developments J Nucl Cardiol 3 1996 516 537
3. S. Iskander, A.E. Iskandrian Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging J Am Coll Cardiol 32 1998 57 62
4. A.S. Iskandrian, S.C. Chae, J. Heo, C.D. Stanberry, V. Wasserleben, V. Cave Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease J Am Coll Cardiol 22 1993 665 670
5. A. Rozanski, H. Gransar, S.W. Hayes, J.D. Friedman, R. Hachamovitch, D.S. Berman Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT J Nucl Cardiol 17 2010 999 1008
6. D.S. Berman, X. Kang, S.W. Hayes Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men Impact of diabetes mellitus on incremental prognostic value and effect on patient management J Am Coll Cardiol 41 2003 1125 1133
7. A.M. Amanullah, D.S. Berman, J. Erel Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease Am J Cardiol 82 1998 725 730
8. R. Hachamovitch, D.S. Berman, H. Kiat Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia Am J Cardiol 80 1997 426 433
9. R.C. Hendel, T. Jamil, D.K. Glover Pharmacologic stress testing: new methods and new agents J Nucl Cardiol 10 2003 197 204
10. R.C. Hendel, T.M. Bateman, M.D. Cerqueira Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging J Am Coll Cardiol 46 2005 2069 2075
11. M.I. Miyamoto, S.L. Vernotico, H. Majmundar, G.S. Thomas Pharmacologic stress myocardial perfusion imaging: a practical approach J Nucl Cardiol 14 2007 250 255
12. G.S. Thomas, B.R. Tammelin, G.L. Schiffman Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial) J Nucl Cardiol 15 2008 319 328
13. B.R. Leaker, B. O'Connor, T.T. Hansel Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial J Nucl Cardiol 15 2008 329 336
14. W. Al Jaroudi, A.E. Iskandrian Regadenoson: a new myocardial stress agent J Am Coll Cardiol 54 2009 1123 1130
15. A.E. Iskandrian, T.M. Bateman, L. Belardinelli Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial J Nucl Cardiol 14 2007 645 658
16. J.J. Mahmarian, M.D. Cerqueira, A.E. Iskandrian Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial J Am Coll Cardiol Img 2 2009 959 968
17. A.E. Iskandrian Stress-only myocardial perfusion imaging a new paradigm J Am Coll Cardiol 55 2010 231 233
18. A.E. Iskandrian, E.V. Garcia, T. Faber, J.J. Mahmarian Automated assessment of serial SPECT myocardial perfusion images J Nucl Cardiol 16 2009 6 9
19. D.S. Berman, X. Kang, H. Gransar Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis J Nucl Cardiol 16 2009 45 53
20. F.G. Hage, R. Venkataraman, W. Aljaroudi The impact of viability assessment using myocardial perfusion imaging on patient management and outcome J Nucl Cardiol 17 2010 378 389
21. G. Germano, H. Kiat, P.B. Kavanagh Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 1995 2138 2147
22. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
23. P. Meyer, G.S. Filippatos, M.I. Ahmed Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure Circulation 121 2010 252 258
24. W.S. Aronow, M.I. Ahmed, O.J. Ekundayo, R.M. Allman, A. Ahmed A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults Am J Cardiol 103 2009 130 135
25. A.H. Wu, B. Pitt, S.D. Anker, J. Vincent, M. Mujib, A. Ahmed Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age Eur J Heart Fail 12 2010 566 573
26. Z. Gao, Z. Li, S.P. Baker Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists J Pharmacol Exp Ther 298 2001 209 218
27. W. Aljaroudi, D. Hermann, F. Hage, J. Heo, A.E. Iskandrian Safety of regadenoson in patients with end-stage renal disease Am J Cardiol 105 2010 133 135
28. H.D. Lieu, J.C. Shryock, G.O. von Mering Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans J Nucl Cardiol 14 2007 514 520
29. The Myocardial Perfusion Imaging Market Guide (U.S.) Supplement to the U.S. Imaging Market Guide 2011 Arlington Medical Resources, Inc Malvern, PA
30. M.D. Cerqueira, P. Nguyen, P. Staehr, S.R. Underwood, A.E. Iskandrian Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results J Am Coll Cardiol Img 1 2008 307 316
31. R. Hachamovitch, D.S. Berman, L.J. Shaw Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction Circulation 97 1998 535 543
32. H.A. Dakik, J.A. Wendt, K. Kimball, C.M. Pratt, J.J. Mahmarian Prognostic value of adenosine Tl-201 myocardial perfusion imaging after acute myocardial infarction: results of a prospective clinical trial J Nucl Cardiol 12 2005 276 283
33. M.L. Ladenheim, T.S. Kotler, B.H. Pollock, D.S. Berman, G.A. Diamond Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease Am J Cardiol 59 1987 270 277
34. D.S. Berman, R. Hachamovitch, H. Kiat Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography J Am Coll Cardiol 26 1995 639 647